Evidence mapPaperPMID 31511931Full record

ArticleDiabetologia2020

Trends in cancer mortality among people with vs without diabetes in the USA, 1988-2015.

Jessica L Harding, Linda J Andes, Edward W Gregg, Yiling J Cheng, Hannah K Weir, Kai M Bullard, Nilka Ríos Burrows, Giuseppina Imperatore

Abstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. New-Onset Diabetes after an Obesity-Related Cancer Diagnosis and Survival Outcomes in the Women's Health Initiative.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jessica L HardingDivision of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop F75, Atlanta, GA, 30341, USA. jharding@cdc.gov.
Linda J AndesDivision of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop F75, Atlanta, GA, 30341, USA.
Edward W GreggDivision of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop F75, Atlanta, GA, 30341, USA.
Yiling J ChengDivision of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop F75, Atlanta, GA, 30341, USA.
Hannah K WeirDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kai M BullardDivision of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop F75, Atlanta, GA, 30341, USA.
Nilka Ríos BurrowsDivision of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop F75, Atlanta, GA, 30341, USA.
Giuseppina ImperatoreDivision of Diabetes Translation, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Mailstop F75, Atlanta, GA, 30341, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisCancer-related death is higher among people with vs without diabetes. However, it is not known if this excess risk has changed over time or what types of cancer may be driving these changes.

methodsTo estimate rates of site-specific cancer mortality in adults with vs without self-reported diagnosed diabetes, we used data from adults aged ≥18 years at the time of the interview who participated in the 1985-2012 National Health Interview Survey. Participants' data were linked to the National Death Index by the National Center for Health Statistics to determine vital status and cause of death through to the end of 2015. Cancer deaths were classified according to underlying cause of death. Death rates for five time periods (1988-1994, 1995-1999, 2000-2004, 2005-2009, 2010-2015) were estimated using discrete Poisson regression models adjusted for age, sex and race/ethnicity with p for linear trend reported (p

resultsAmong adults with diabetes, age-adjusted cancer mortality rates (per 10,000 person-years) declined 25.5% from 39.1 (95% CI 30.1, 50.8) in 1988-1994 to 29.7 (26.6, 33.1) in 2010-2015, p CONCLUSIONS/

interpretationDeclines in cancer mortality rates were observed in adults with and without diabetes. However, adults with diabetes continue to be more likely to die from cancer than people without diabetes. This study highlights the continued need for greater cancer risk-factor mitigation, especially in adults with diabetes.

Indexed as

AdultDiabetes MellitusFemaleHumansMaleMiddle AgedNeoplasmsUnited StatesCancerDiabetesEpidemiologyMortalityTrends

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.